NL-OMON38404已完成4 期
An open prospective randomized long-term effectiveness study, comparing best medical practice with or without adjunctive spinal cord stimulation in patients with chronic diabetic neuropathic pain - SCS-001
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •chronic, peripheral diabetic neuropathic pain that exists for more than one year
- •patient cannot be treated further otherwise according to patient's medical specialist
- •pain sensation on a VAS scale is minimal 5 (recording both for night and day)
排除标准
- •age < 18 years
- •psychological problems
- •neuropathic pain in upper extremities
研究者
相似试验
已完成
不适用
Study comparing best medical practice with or without vagus nerve stimulation (VNS) therapy in pharmacoresistant partial epilepsy patientsEpilepsyISRCTN51185809Cyberonics Europe SA/NV (Belgium)366
招募中
不适用
An open prospective randomized long-term effectiveness study, comparing best medical practice with or without adjunctive spinal cord stimulation in patients with chronic diabetic neuropathic pain.(SCS 001)NL-OMON25218none45
进行中（未招募）
1 期
ong-term, safety and tolerability study of AFQ056 in adolescent patients with Fragile X Syndrome (Open–label)Fragile X syndromeMedDRA version: 15.0Level: PTClassification code 10017324Term: Fragile X syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-002379-40-FRovartis Pharma Services AG180
进行中（未招募）
2 期
A study to determine whether patients who have received OMS906 in two previous studies and responded well to it, continue to tolerate it and maintain a good responseParoxysmal Nocturnal Hemoglobinuria (PNH)Haematological DisordersISRCTN73211658Omeros Corporation (United States)25
进行中（未招募）
1 期
Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial HypercholesterolemiaHomozygous familial hypercholesterolemiaEUCTR2017-003170-13-NLRegeneron Pharmaceuticals, Inc.116